CVS Health Raises 2026 Forecast Due to Improved Medical Cost Controls
CVS Health raised its full-year earnings forecast for 2026, citing improved medical cost controls and strong performance in its pharmacy management business. The company reported a higher-than-expected first-quarter profit of $2.57 per share and expects adjusted EPS between $7.30 to $7.50 for the year.
Tickers: $CVS
Topics: Financial Forecast Healthcare Medical Cost Controls Pharmacy Benefit Manager (PBM)